Literature DB >> 15063715

Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen.

Roselyne Garnotel1, Nadia Sabbah, Stéphane Jaisson, Philippe Gillery.   

Abstract

Carbamylation refers to chemical modification of protein side chains by cyanate derived e.g. from urea. It alters their structural and functional properties. We have studied the influence of the carbamylation of type I collagen in vitro on its interactions with elutriated human monocytes, and its potential role in atherosclerosis. Adhesion of monocytes onto carbamylated collagen was significantly enhanced compared to native collagen. There was no change in superoxide anion production. On the other hand, there was an increase in the production and the activation of matrix metalloproteinase-9. No effect was found on tissue inhibitor of metalloproteinase-1 production. Thus, the presence of carbamylated collagen may stimulate the remodelling of extracellular matrix mediated by activated monocytes. Such alterations may contribute to enhanced atherosclerosis in renal insufficiency, a pathological condition associated with elevated levels of carbamylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063715     DOI: 10.1016/S0014-5793(04)00233-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

Review 2.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

3.  Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.

Authors:  Piotr Mydel; Zeneng Wang; Mikael Brisslert; Annelie Hellvard; Leif E Dahlberg; Stanley L Hazen; Maria Bokarewa
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

Review 4.  Avenues for post-translational protein modification prevention and therapy.

Authors:  Mengyao Tang; Sahir Kalim
Journal:  Mol Aspects Med       Date:  2022-02-25

5.  Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.

Authors:  Sahir Kalim; Caitlin A Trottier; Julia B Wenger; Josh Wibecan; Rayhnuma Ahmed; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani; Anders H Berg
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

6.  Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins.

Authors:  Amy S Chung; Weiyuan John Kao
Journal:  J Biomed Mater Res A       Date:  2009-06-15       Impact factor: 4.396

Review 7.  Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Authors:  Agata N Burska; Laura Hunt; Marjorie Boissinot; Rocky Strollo; Brent J Ryan; Ed Vital; Ahuva Nissim; Paul G Winyard; Paul Emery; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

Review 8.  Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases.

Authors:  Brent J Ryan; Ahuva Nissim; Paul G Winyard
Journal:  Redox Biol       Date:  2014-05-28       Impact factor: 11.799

Review 9.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

10.  Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD.

Authors:  Christine Pietrement; Laëtitia Gorisse; Stéphane Jaisson; Philippe Gillery
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.